Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 11/20 | 0.63 |
| ▸ | ECE1 | P42892 | 2/20 | 0.61 |
| ▸ | CCKBR | P32239 | 2/20 | 0.60 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.59 |
| ▸ | IL1RN | P18510 | 2/20 | 0.58 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.58 |
| ▸ | GHSR | Q92847 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10419482 | 0.94 | KISS1R (0.68) | KISS1RECE1 | |
| SCHEMBL31337768 | 0.89 | ERAP2 (0.67) | ECE1ERAP2IL1RNERAP1 | |
| SCHEMBL31563651 | 0.89 | ERAP2 (0.67) | ECE1ERAP2IL1RNERAP1 | |
| SCHEMBL30051984 | 0.89 | ERAP2 (0.67) | ECE1ERAP2IL1RNERAP1 | |
| SCHEMBL29828658 | 0.89 | ERAP2 (0.67) | ECE1ERAP2IL1RNERAP1 | |
| SCHEMBL24899406 | 0.89 | CCKBR (0.62) | KISS1RECE1CCKBRERAP2IL1RN | |
| SCHEMBL30721645 | 0.89 | CCKBR (0.64) | KISS1RECE1CCKBRGHSR | |
| Hydrochloric Acid SCHEMBL11568837 | 0.89 | NPY1R (0.62) | KISS1RCCKBR | |
| SCHEMBL9854702 | 0.88 | KISS1R (0.67) | KISS1RECE1CCKBRERAP2IL1RN | |
| SCHEMBL29702204 | 0.88 | CCKBR (0.66) | KISS1RCCKBRGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4172130-A | α-AMINOACYL CONTAINING NEW PEPTIDES WITH GASTRIN EFFECTS AND A PROCESS FOR THE PREPARATION THEREOF | RICHTER GEDEON VEGYESZETI GYAR RT (HU) | 1979-10-23 | — | — | US | disclosed |